NextFin News - The U.S. State Department is weighing a plan to withhold lifesaving H.I.V. assistance from Zambia as a high-stakes lever to force the southern African nation into a critical minerals agreement. According to a draft memo prepared for U.S. Secretary of State Marco Rubio by the department’s Africa Bureau, the Trump administration is considering "significantly cutting assistance" as early as May. The document, first reported by the New York Times, suggests that the U.S. can only secure its strategic priorities by demonstrating a "willingness to publicly take support away from Zambia on a massive scale."
This pivot marks a radical departure from two decades of American global health policy. Since its inception in 2003, the President’s Emergency Plan for AIDS Relief (PEPFAR) has been the cornerstone of U.S. soft power in Africa, credited with saving 25 million lives and turning the tide of the global epidemic. In Zambia, where roughly 1.3 million people live with H.I.V., PEPFAR funding provides the antiretroviral drugs that keep the vast majority of them alive. By tethering this humanitarian lifeline to the extraction of cobalt and copper, U.S. President Trump is signaling that the era of "no-strings-attached" health diplomacy has ended, replaced by a transactional "America First" doctrine that prioritizes the domestic electric vehicle supply chain over global health stability.
The timing of this pressure campaign is not accidental. Zambia sits atop some of the world’s largest deposits of high-grade copper and cobalt, minerals essential for the batteries that power everything from smartphones to the U.S. defense industrial base. As the U.S. races to reduce its dependence on Chinese processing and mining, the Copperbelt has become a frontline in the new Cold War. While the previous administration focused on the Lobito Corridor—a rail project designed to export minerals through Angola—the current U.S. President appears dissatisfied with the pace of progress. The memo indicates that the State Department views the threat of an aid cutoff as the only way to break the "bureaucratic inertia" in Lusaka and secure preferential access for American firms.
For Zambia, the stakes are existential. Julius Kachidza, a 56-year-old advocate for people living with H.I.V., told the New York Times that the government has "no capacity" to fill the funding gap if Washington pulls out. A sudden withdrawal would not only lead to a spike in mortality but could also trigger drug resistance on a scale that would threaten regional health security. Economically, the country is already struggling under a massive debt burden, much of it owed to Chinese lenders. If President Hakainde Hichilema yields to U.S. demands, he risks alienating Beijing; if he refuses, he faces a public health catastrophe that could destabilize his presidency.
The strategy carries significant risks for Washington as well. By weaponizing PEPFAR, the U.S. President may inadvertently hand a propaganda victory to China and Russia, who have long characterized American aid as a tool of neo-colonialism. If the Trump administration follows through on the May deadline, it will likely face fierce bipartisan pushback in Congress, where PEPFAR has historically enjoyed rare consensus. However, the memo suggests that Rubio and his team believe the strategic necessity of securing "green" minerals outweighs the reputational damage of abandoning H.I.V. patients. The coming weeks will determine whether this is a bluff designed to accelerate negotiations or a permanent shift toward a more predatory form of resource diplomacy.
Explore more exclusive insights at nextfin.ai.
